Europeiska unionen -
engelska -
EMA (European Medicines Agency)
nityr
cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - other alimentary tract and metabolism products, - treatment of adult and paediatric patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.
Kanada -
engelska -
Health Canada
orfadin capsule
swedish orphan biovitrum ab (publ) - nitisinone - capsule - 2mg - nitisinone 2mg - other miscellaneous therapeutic agents
Kanada -
engelska -
Health Canada
orfadin capsule
swedish orphan biovitrum ab (publ) - nitisinone - capsule - 5mg - nitisinone 5mg - other miscellaneous therapeutic agents
Kanada -
engelska -
Health Canada
orfadin capsule
swedish orphan biovitrum ab (publ) - nitisinone - capsule - 10mg - nitisinone 10mg - other miscellaneous therapeutic agents
Kanada -
engelska -
Health Canada
orfadin capsule
swedish orphan biovitrum ab (publ) - nitisinone - capsule - 20mg - nitisinone 20mg - other miscellaneous therapeutic agents
Kanada -
engelska -
Health Canada
orfadin suspension
swedish orphan biovitrum ab (publ) - nitisinone - suspension - 4mg - nitisinone 4mg - other miscellaneous therapeutic agents
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
orfadin 2mg capsules
swedish orphan biovitrum ltd - nitisinone - capsule - 2mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
orfadin 5mg capsules
swedish orphan biovitrum ltd - nitisinone - capsule - 5mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
orfadin 10mg capsules
swedish orphan biovitrum ltd - nitisinone - capsule - 10mg
Storbritannien -
engelska -
MHRA (Medicines & Healthcare Products Regulatory Agency)
orfadin 20mg capsules
swedish orphan biovitrum ltd - nitisinone - capsule - 20mg